UnitedHealth Group Q4 EPS $0.01 vs $5.98 a year ago; 2026 EPS outlook above $17.10
UnitedHealth reported fourth quarter and full year 2025 results on January 27, 2026. Full year revenue rose to $447.6 billion, but diluted earnings per share fell to $13.23 from $15.51, after a fourth quarter charge of $1.6 billion net of taxes, or $1.78 per share. The company also issued 2026 guidance calling for diluted earnings per share above $17.10 and adjusted earnings per share above $17.75.
Key points
- Q4 2025 diluted EPS was $0.01 versus $5.98 in Q4 2024; adjusted EPS was $2.11 versus $6.81
- Full year 2025 revenue was $447.6 billion, up 12% year over year; diluted EPS was $13.23 versus $15.51 in 2024
- Q4 2025 included a $1.6 billion net-of-tax charge ($1.78 per share) tied to cyberattack costs, divestitures, and restructuring
- 2026 outlook: revenue above $439.0 billion, earnings from operations above $24.0 billion, and cash flows from operations above $18.0 billion
The filing
Written by AI on Nov 8, 2026, 2:16 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 27, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.